Evaluation of Protective Immune Response Induced by a DNA Vaccine Encoding GRA8 against Acute Toxoplasmosis in a Murine Model

키워드

참고문헌 (44)

1. Dubey JP, "The history of Toxoplasma gondii-the first 100 years", J Eukaryot Microbiol, 55, pp.467~475 (2008)[DOI]
2. Dubey JP, "High prevalence and genotypes of Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA", Int J Parasitol, 41, pp.827~833 (2011)[DOI]
3. Nissapatorn V, "Toxoplasmosis in HIV", AIDS patients: a current situation, 2004, pp.57, 160~165
4. Thomas F, "Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common", Biol Lett, 8, pp.101~103 (2012)[DOI]
5. Lebech M, "Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment", Lancet, 353, pp.1834~1837 (1999)[DOI]
6. Dubey JP, "Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers", J Parasitol, 91, pp.1082~1093 (2005)[DOI]
7. Fajardo HV, "Seroprevalence and risk factors of toxoplasmosis in cattle from extensive and semi-intensive rearing systems at Zona da Mata, Minas Gerais state, Southern Brazil", Parasit Vectors, 6, pp.191~ (2013)[DOI]
8. Dubey JP, "Toxoplasmosis in pigs-the last 20 years", Vet Parasitol, 164, pp.89~103 (2009)[DOI]
9. Abugri DA, "In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii", Parasitol Res, 116, pp.3387~3400 (2017)[DOI]
10. Zhu WN, "Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice", Exp Parasitol, 179, pp.20~27 (2017)[DOI]
11. Buxton D, "A commercial vaccine for ovine toxoplasmosis", Parasitology, 110(suppl), pp.11~16 (1995)[DOI]
12. Cao A, "Toxoplasma gondii: vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice", Vaccine, 33, pp.6757~6762 (2015)[DOI]
13. Belakova J, "DNA vaccines: are they still just a powerful tool for the future", Arch Immunol Ther Exp (Warsz), 55, pp.387~398 (2007)[DOI]
14. Henriquez FL, "Immunogenetics of Toxoplasma gondii informs vaccine design", Trends in Parasitol, 26, pp.550~555 (2010)[DOI]
15. Hiszczynska-Sawicka E, "DNA vaccines and recombinant antigens in prevention of Toxoplasma gondii infections--current status of the studies", Wiad Parazytol, 55, pp.125~139 (2009)
16. Mendes EA, "Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1", PLoS One, 8, pp.e63201~ (2013)[DOI]
17. Cong H, "Compound DNA vaccine encoding SAG1", SAG3 with A2, c mice against Toxoplasma gondii, pp.Parasit Vectors, 2013[DOI]
18. Zhou J, "SAG4 DNA and peptide vaccination provides partial protection against T. gondii infection in BALB", c mice, 2017, pp.8, 1733~
19. Hiszczynska-Sawicka E, "Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii", Vet Parasitol, 177, pp.281~289 (2011)[DOI]
20. Ahmadpour E, "Evaluation of the immune response in BALB", c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii, 2017, pp.39, e12419~
21. Yuan ZG, "Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model", Vaccine, 31, pp.3135~3139 (2013)[DOI]
22. Liu Q, "Toxoplasma gondii: immune response and protective efficacy induced by ROP16", GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2, 2014, pp.10, 184~191
23. Wang HL, "DNA vaccination with a gene encoding Toxoplasma gondii rhoptry protein 17 induces partial protective immunity against lethal challenge in mice", Parasite, 23, pp.4~ (2016)[DOI]
24. Nabi H, "Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii", Parasitol Res, 116, pp.359~370 (2017)[DOI]
25. Hu LY, "Resistance to Chronic Toxoplasma gondii infection induced by a DNA vaccine expressing GRA16", Biomed Res Int, 2017, pp.1295038~ (2017)
26. Quan JH, "Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii", Clin Vaccine Immunol, 19, pp.666~674 (2012)[DOI]
27. Babaie J, "Bacterial production of dense granule antigen GRA8 of Toxoplasma gondii", Iran Biomed J, 13, pp.145~151 (2009)
28. Babaie J, "Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli", Avicenna J Med Biotechnol, 3, pp.67~77 (2011)
29. Costa JG, "Immunochemical evaluation of two Toxoplasma gondii GRA8 sequences to detect acute toxoplasmosis infection", Microb Pathog, 100, pp.229~236 (2016)[DOI]
30. Verma R, "Development of Toxoplasma gondii vaccine: a global challenge", Hum Vaccin Immunother, 9, pp.291~293 (2013)[DOI]
31. Ching XT, "Evaluation of the protective effect of deoxyribonucleic acid vaccines encoding granule antigen 2 and 5 against acute Toxoplasmosis in BALB", c Mice, 2017, pp.96, 1441~1447
32. Chen J, "DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice", Expert Rev Vaccines, 14, pp.617~624 (2015)[DOI]
33. Yuan ZG, "Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18", Vaccine, 29, pp.6614~6619 (2011)[DOI]
34. Zheng L, "Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii", Acta Trop, 166, pp.336~342 (2017)[DOI]
35. Wang M, "Evaluation of protective immune responses induced by recombinant TrxLp and ENO2 proteins against Toxoplasma gondii infection in BALB", c mice, 2016, pp.2016, 3571962~
36. Chen K, "Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2)", Parasite, 24, pp.41~ (2017)[DOI]
37. Zhang NZ, "Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice", Expert Rev Vaccines, 14, pp.1289~1297 (2015)[DOI]
38. Xu Y, "Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model", BMC Infect Dis, 14, pp.525~ (2014)[DOI]
39. Yali Han, "DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice", Parasites, Hosts and Diseases, 55(5), pp.505~512 (2017), 대한기생충학ㆍ열대의학회
40. Lee SH, "Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection", PLoS One, 12, pp.e0175644~ (2017)[DOI]
41. Han Y, "Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB", c mice, 2017, pp.17, 59~
42. Liu CH, "Cutting edge: dendritic cells are essential for in vivo IL 12 production and development of resistance against Toxoplasma gondii infection in mice", J Immunol, 177, pp.31~35 (2006)[DOI]
43. Gazzinelli RT, "Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii", J Immunol, 153, pp.2533~2543 (1994)
44. Hunter CA, "Modulation of innate immunity by Toxoplasma gondii virulence effectors", Nat Rev Microbiol, 10, pp.766~778 (2012)[DOI]

관련 논문AI추천